ZeaKal lands $5.3 mln Series B, acquires VC-backed Algenetix
ZeaKal, a biotechnology startup focused on improving agricultural productivity, raised $5.3 million in a Series B financing round led by Finistere Ventures. Middleland Capital and several family office investors participated in the oversubscribed round. ZeaKal also acquired Algenetix, a biotechnology company developing renewable materials and energies from plant-based sources. Financial terms of the transaction were not disclosed. In 2013, Algenetix raised $2 million in a Series A funding round led by Two Oceans, according to a separate press release.
17 February 2016•4 mins read
